The potential of bovine vaginal smear for biomarker development to trace the misuse of anabolic agents

Exp Clin Endocrinol Diabetes. 2011 Feb;119(2):86-94. doi: 10.1055/s-0030-1267239. Epub 2010 Oct 28.

Abstract

In the European Union the use of anabolic hormones in meat production is forbidden since 1988 and this ban of anabolic agents in animal production is strictly controlled. New hormone cocktails passing the detection systems are attractive for the practice and so new approaches to discover their illegal use have to be developed steadily. Verifying physiological effects caused by anabolic steroids will be a new way to develop potential monitoring systems. One promising matrix in female animals will be vaginal smear containing vaginal epithelial cells, because the vaginal epithelium is a primary steroid hormone responsive organ. In this study we quantified the gene expression in vaginal smear of sexually mature cattle in order to observe physiological effects. Further we aimed to establish a new screening method by testing the effect of a combination of certain anabolic steroid hormones on physiological regulations of mRNA expression of selected genes. In an animal trial Nguni heifers were treated with the anabolic combination trenbolone acetate plus estradiol. Vaginal smear samples were taken at 4 different time points. Gene expression of 27 candidate genes, selected by screening the actual literature for steroidal effects on vaginal epithelial cells, were estimated using quantitative real-time RT-PCR. There were different expression changes observed at different time points. It could be shown that the applied anabolic combination significantly influenced the expression of the steroid receptor ERα, the keratinization factor CK8, the proinflammatory interleukins IL-1α and IL-1β, the growth factors FGF7, EGF, EGFR, IGF-1R, TGFα and LTF, the oncogen c-jun and other factors like actinβ and ubiquitin 3. Using biostatistical tools like principal components analysis or hierarchical cluster analysis, the potential to develop a gene expression pattern for targeting the illegal use of growth promoters could be demonstrated.

Publication types

  • Controlled Clinical Trial
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Anabolic Agents* / analysis
  • Anabolic Agents* / isolation & purification
  • Animals
  • Biomarkers, Pharmacological / analysis*
  • Cattle* / growth & development
  • Cattle* / physiology
  • Drug Combinations
  • Drug Implants
  • Estradiol / administration & dosage
  • Female
  • Meat Products / analysis
  • Meat Products / standards
  • Progesterone / blood
  • RNA Stability / physiology
  • Reverse Transcriptase Polymerase Chain Reaction / methods
  • Reverse Transcriptase Polymerase Chain Reaction / standards
  • Substance Abuse Detection / methods*
  • Substance Abuse Detection / veterinary
  • Trenbolone Acetate / administration & dosage
  • Trenbolone Acetate / analogs & derivatives
  • Vaginal Smears / statistics & numerical data
  • Vaginal Smears / veterinary*

Substances

  • Anabolic Agents
  • Biomarkers, Pharmacological
  • Drug Combinations
  • Drug Implants
  • Revalor
  • Progesterone
  • Estradiol
  • Trenbolone Acetate